kidney
Vanrafia Receives Accelerated Approval
The FDA granted accelerated approval to Vanrafia for proteinuria reduction in primary immunoglobulin A nephropathy.
APRIL 24, 2025
FDA Grants Third Indication to Fabhalta for C3G
The FDA granted a new indication for iptacopan to treat adults with C3 glomerulopathy (C3G) to reduce proteinuria, ...
MARCH 26, 2025
New Guideline Aims for Safer Renal Dosing in Cancer Patients
A draft of the new International Consensus Guideline on Anticancer Drug Dosing in Kidney Dysfunction was recently ...
MAY 10, 2022
New International Guidelines to Aid Anticancer Drug Dosing in Patients With Kidney Dysfunction
A draft of new international guidelines on cancer drug dosing in patients with kidney dysfunction was previewed at ...
MARCH 7, 2022
Time to Switch To Race-Free eGFR Renal Test?
Using a race-free version of the estimated glomerular filtration rate Chronic Kidney Disease Epidemiology ...
FEBRUARY 10, 2022
Potassium-Sparing Agents Put a Rise in RAASis
Newer agents are reenergizing the treatment of hyperkalemia, a serious condition characterized by elevated serum ...
JUNE 10, 2021
FDA Grants New Indication to Farxiga to Prevent Progression of CKD
Dapagliflozin already has an indication for improving glycemic control and reducing the risk for hospitalization ...
MAY 4, 2021
HCV-Infected Kidneys Function As Well As Uninfected Organs
Kidneys from donors who were infected with hepatitis C virus (HCV) function as well as uninfected organs throughout ...
OCTOBER 24, 2019
